Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
1.490
-0.140 (-8.59%)
At close: Aug 7, 2026, 4:00 PM EDT
1.483
-0.007 (-0.46%)
After-hours: Aug 7, 2026, 7:59 PM EDT
Nuwellis Revenue
Nuwellis had revenue of $2.40M in the quarter ending March 31, 2026, with 26.21% growth. This brings the company's revenue in the last twelve months to $8.77M, down -0.20% year-over-year. In the year 2025, Nuwellis had annual revenue of $8.27M, down -5.38%.
Revenue (ttm)
$8.77M
Revenue Growth
-0.20%
P/S Ratio
0.02
Revenue / Employee
$230,763
Employees
38
Market Cap
218.41K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.27M | -470.00K | -5.38% |
| Dec 31, 2024 | 8.74M | -124.00K | -1.40% |
| Dec 31, 2023 | 8.86M | 321.00K | 3.76% |
| Dec 31, 2022 | 8.54M | 622.00K | 7.85% |
| Dec 31, 2021 | 7.92M | 480.00K | 6.45% |
| Dec 31, 2020 | 7.44M | 1.93M | 35.02% |
| Dec 31, 2019 | 5.51M | 513.00K | 10.26% |
| Dec 31, 2018 | 5.00M | 1.45M | 40.67% |
| Dec 31, 2017 | 3.55M | 2.26M | 175.64% |
| Dec 31, 2016 | 1.29M | 1.23M | 2,084.75% |
| Dec 31, 2015 | 59.00K | -236.00K | -80.00% |
| Dec 31, 2014 | 295.00K | 236.00K | 400.00% |
| Dec 31, 2013 | 59.00K | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | 407.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vivos Therapeutics | 19.57M |
| Beyond Air | 7.68M |
| INVO Fertility | 7.22M |
| Tenon Medical | 4.60M |
| Biomerica | 4.33M |
| Intelligent Bio Solutions | 3.91M |
| ENvue Medical | 2.18M |
| Catheter Precision | 1.11M |
NUWE News
- 3 days ago - Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer - GlobeNewsWire
- 5 days ago - Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications - GlobeNewsWire
- 9 days ago - Nuwellis prices $3.4M at-the-market offering at $2.59 per share - TheFly
- 9 days ago - Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 10 days ago - Why Is Penny Stock Nuwellis (NUWE) Up Today? - TipRanks
- 10 days ago - Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy - GlobeNewsWire
- 12 days ago - Nuwellis Expands Pediatric Footprint with First Aquadex SmartFlow® Installations in Wisconsin - GlobeNewsWire
- 13 days ago - Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth - GlobeNewsWire